A Message from Paul V. Campanelli
Chief Executive Officer

I am pleased that you have chosen to visit Par’s website to learn more about our Company. Par has been faithfully serving the needs of physicians, patients and trade customers since 1978. In a rapidly changing industry, Par remains steadfast in our commitment to deliver pharmaceutical products of uncompromising quality and value. Our reputation for quality represents a competitive advantage and positions Par as a leader in quality within our industry.

Our Company develops, manufactures, markets and distributes safe, innovative and cost-effective pharmaceuticals that help improve patient quality of life. Par’s sales place it among the leading generic pharmaceutical companies in the U.S. Par Pharmaceutical offers a line of high-barrier-to-entry, cost-effective generic drugs, while Par Specialty Pharmaceuticals provides niche, innovative brands. Par Sterile Products develops, manufactures and markets both branded and generic aseptic injectable pharmaceuticals.

Par’s growth has propelled its revenues beyond the $1.3 billion threshold, increased our workforce to almost 1,900 colleagues, broadened our development efforts, and expanded our technologies and array of dosage forms. In addition to oral solid dosage, including extended-release products, Par also provides physicians and patients with liquids, nasal sprays, injectables, thin films and transdermal patches. Today, Par has nearly 100 products in active development and almost 120 Abbreviated New Drug Applications awaiting FDA approval, including almost 40 potential first-to-file and first-to-market opportunities. The quality of this development pipeline is unprecedented in our company’s history.

These accomplishments can be attributed to an experienced management team and our most important resource - - the imagination of our highly-valued colleagues. Par’s unique culture is imbued with an entrepreneurial spirit and an adherence to our Core Values, which has created a performance-driven organization that values integrity, customer focus and teamwork. The result - - a fully integrated, mid-sized pharmaceutical company, with scale, diversification and a track record of long-term value creation, unlike any other in our industry.
Paul V. Campanelli
Chief Executive Officer